DX D Biotech T 5 Bull 2X ETFTBXUETF
13F holders, Q1 2026 (March 31)3holders
0new positions
0sold out
$31.36avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding DX D Biotech T 5 Bull 2X ETF (TBXU) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Goldman Sachs Group Inc. ($784K), Bank of America Corp. ($784K) and GTS Securities LLC ($479K).
- Company
- DX D Biotech T 5 Bull 2X ETF
- Filed as
- DIREXION SHARES ETF TRUST (Q1 2026)
- CUSIP
- 25461H101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 8,036 shares sold, net −8,036 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Goldman Sachs Group Inc. | 0.00% | No change | 25,000 | $784K |
| Bank of America Corp. | 0.00% | No change | 25,000 | $784K |
| GTS Securities LLC | 0.02% | Reduce -34.5% | 15,274 | $479K |
"% of holder's portfolio" is TBXU's weight in each manager's 13F, not the share of DX D Biotech T 5 Bull 2X ETF the manager owns.